Monday, August 13, 2012
Updated information about Biomarin's BMN-111 clinical development
Biomarin has updated its website, posting more detailed information regarding the clinical development of BMN-111, a CNP analogue, the first potential pharmacological therapy for achondroplasia reaching clinical trials.
For more details, you can visit: http://www.biomarinclinicaltrials.com/Achondroplasia.html.
You can learn more about CNP reading this previous article published in the blog: